These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

227 related items for PubMed ID: 3708564

  • 1. Suppression of choline-deficient diet-induced hepatocyte membrane lipid peroxidation in rats by the peroxisome proliferators 4-chloro-6-(2,3-xylidino)-2-pyrimidinylthio(N-beta-hydroxyethyl)- acetamide and di(2-ethylhexyl)phthalate.
    Perera MI, Katyal SL, Shinozuka H.
    Cancer Res; 1986 Jul; 46(7):3304-8. PubMed ID: 3708564
    [Abstract] [Full Text] [Related]

  • 2. Accelerated regression of carcinogen-induced preneoplastic hepatocyte foci by peroxisome proliferators, BR931, 4-chloro-6-(2,3-xylidino)-2-pyrimidinylthio (N-B-hydroxyethyl)acetamide, and di-(2-ethylhexyl)phthalate.
    Perera MI, Shinozuka H.
    Carcinogenesis; 1984 Sep; 5(9):1193-8. PubMed ID: 6147206
    [Abstract] [Full Text] [Related]

  • 3. Peroxisome proliferation and lipid peroxidation in rat liver.
    Goel SK, Lalwani ND, Reddy JK.
    Cancer Res; 1986 Mar; 46(3):1324-30. PubMed ID: 3943099
    [Abstract] [Full Text] [Related]

  • 4. Suppression of EGF binding in rat liver by the hypolipidemic peroxisome proliferators, 4-chloro-6-(2,3-xylidino)-2-pyrimidinylthio-(N-beta-hydroxyethyl)ac etamide and di(2-ethylhexyl)phthalate.
    Gupta C, Hattori A, Shinozuka H.
    Carcinogenesis; 1988 Jan; 9(1):167-9. PubMed ID: 3257172
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Differential expression of hepatocyte growth factor, transforming growth factor-alpha and transforming growth factor-beta 1 messenger RNAs in two experimental models of liver cell proliferation.
    Masuhara M, Katyal SL, Nakamura T, Shinozuka H.
    Hepatology; 1992 Nov; 16(5):1241-9. PubMed ID: 1427663
    [Abstract] [Full Text] [Related]

  • 10. Effect of di(2-ethylhexyl) phthalate on DNA repair and lipid peroxidation in rat hepatocytes and on metabolic cooperation in Chinese hamster V-79 cells.
    Kornbrust DJ, Barfknecht TR, Ingram P, Shelburne JD.
    J Toxicol Environ Health; 1984 Nov; 13(1):99-116. PubMed ID: 6716514
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Response of hepatocytes transplanted into syngeneic hosts and heterotransplanted into athymic nude mice to peroxisome proliferators.
    Reddy JK, Jirtle RL, Watanabe TK, Reddy NK, Michalopoulos G, Qureshi SA.
    Cancer Res; 1984 Jun; 44(6):2582-9. PubMed ID: 6372995
    [Abstract] [Full Text] [Related]

  • 13. Specific changes in the protein composition of rat liver in response to the peroxisome proliferators ciprofibrate, Wy-14,643 and di-(2-ethylhexyl)phthalate.
    Watanabe T, Lalwani ND, Reddy JK.
    Biochem J; 1985 May 01; 227(3):767-75. PubMed ID: 4004798
    [Abstract] [Full Text] [Related]

  • 14. Characteristics of the hepatocarcinogenesis caused by dehydroepiandrosterone, a peroxisome proliferator, in male F-344 rats.
    Hayashi F, Tamura H, Yamada J, Kasai H, Suga T.
    Carcinogenesis; 1994 Oct 01; 15(10):2215-9. PubMed ID: 7955056
    [Abstract] [Full Text] [Related]

  • 15. Concentration-dependent inhibition of development of GGT positive foci in rat liver by the environmental contaminant di(2-ethylhexyl) phthalate.
    DeAngelo AB, Queral AE, Garrett CT.
    Environ Health Perspect; 1985 May 01; 60():381-5. PubMed ID: 2863135
    [Abstract] [Full Text] [Related]

  • 16. Free radical injury and liver tumor promotion.
    Perera MI, Betschart JM, Virji MA, Katyal SL, Shinozuka H.
    Toxicol Pathol; 1987 May 01; 15(1):51-9. PubMed ID: 3554467
    [Abstract] [Full Text] [Related]

  • 17. Relationship of oxidative damage to the hepatocarcinogenicity of the peroxisome proliferators di(2-ethylhexyl)phthalate and Wy-14,643.
    Conway JG, Tomaszewski KE, Olson MJ, Cattley RC, Marsman DS, Popp JA.
    Carcinogenesis; 1989 Mar 01; 10(3):513-9. PubMed ID: 2924396
    [Abstract] [Full Text] [Related]

  • 18. A cancer risk assessment of di(2-ethylhexyl)phthalate: application of the new U.S. EPA Risk Assessment Guidelines.
    Doull J, Cattley R, Elcombe C, Lake BG, Swenberg J, Wilkinson C, Williams G, van Gemert M.
    Regul Toxicol Pharmacol; 1999 Jun 01; 29(3):327-57. PubMed ID: 10388618
    [Abstract] [Full Text] [Related]

  • 19. Peroxisome proliferator-induced alterations in the expression and modification of rat hepatocyte plasma membrane proteins.
    Bartles JR, Khuon S, Lin XH, Zhang LQ, Reddy JK, Rao MS, Isoye ST, Nehme CL, Fayos BE.
    Cancer Res; 1990 Feb 01; 50(3):669-76. PubMed ID: 2404574
    [Abstract] [Full Text] [Related]

  • 20. Induction of altered hepatic foci in rats by the administration of hypolipidemic peroxisome proliferators alone or following a single dose of diethylnitrosamine.
    Glauert HP, Beer D, Rao MS, Schwarz M, Xu YD, Goldsworthy TL, Coloma J, Pitot HC.
    Cancer Res; 1986 Sep 01; 46(9):4601-6. PubMed ID: 2873887
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.